Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Common Stock | 2.6M | $0.00 | $0 | By Greylock XII Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Common Stock | 288.5k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series B-1 Preferred Stock | 181.1k | $0.00 | $0 | By Greylock XII Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series C-1 Preferred Stock | 93.7k | $0.00 | $0 | By Greylock XII Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series D-1 Preferred Stock | 401.3k | $0.00 | $0 | By Greylock XII Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series E-1 Preferred Stock | 279.8k | $0.00 | $0 | By Greylock XII Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series F Preferred Stock | 577.9k | $0.00 | $0 | By Greylock XII Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series F-1 Preferred Stock | 872.2k | $0.00 | $0 | By Greylock XII Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series G Preferred Stock | 190.4k | $0.00 | $0 | By Greylock XII Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series B-1 Preferred Stock | 20.1k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series C-1 Preferred Stock | 10.4k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series D-1 Preferred Stock | 44.6k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series E-1 Preferred Stock | 31.1k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series F Preferred Stock | 64.2k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series F-1 Preferred Stock | 96.9k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 09/30/2019 |
09/30/2019 | Oportun Financial Corp | OPRT | Conversion | Series G Preferred Stock | 21.2k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 09/30/2019 |
02/27/2018 | Redfin Corp | RDFN | Other (disposition) | Common Stock | 1.9M | $0.00 | $0 | By Greylock XII Limited Partnership | 02/27/2018 |
02/27/2018 | Redfin Corp | RDFN | Other (disposition) | Common Stock | 206.6k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 02/27/2018 |
10/02/2017 | Cloudera, Inc. | CLDR | Sale | Common Stock | 3.2M | $15.79 | $50.8M | By Greylock XII Limited Partnership | 10/02/2017 |
10/02/2017 | Cloudera, Inc. | CLDR | Sale | Common Stock | 357.5k | $15.79 | $5.6M | By Greylock XII-A Limited Partnership | 10/02/2017 |
05/09/2017 | Apptio Inc | APTI | Sale | Class A Common Stock | 2.7M | $13.00 | $35.2M | By Greylock XII Limited Partnership | 05/09/2017 |
05/09/2017 | Apptio Inc | APTI | Sale | Class A Common Stock | 301k | $13.00 | $3.9M | By Greylock XII-A Limited Partnership | 05/09/2017 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Common Stock | 302.7k | $0.00 | $0 | By Greylock XII Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Common Stock | 60.5k | $0.00 | $0 | By Greylock XII Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Common Stock | 26.9k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Common Stock | 33.6k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Common Stock | 6.7k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Series A Convertible Preferred Stock | 1.4M | $0.00 | $0 | By Greylock XII Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Series B Convertible Preferred Stock | 1.7M | $0.00 | $0 | By Greylock XII Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Series C Convertible Preferred Stock | 342k | $0.00 | $0 | By Greylock XII Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Series A Convertible Preferred Stock | 152k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Series B Convertible Preferred Stock | 190k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Series C Convertible Preferred Stock | 38k | $0.00 | $0 | By Greylock XII-A Limited Partnership | 02/19/2014 |
02/19/2014 | CONCERT PHARMACEUTICALS, INC. | CNCE | Conversion | Common Stock | 242.1k | $0.00 | $0 | By Greylock XII Limited Partnership | 02/19/2014 |